A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma.
Zheng Y, Tian H, Zhou Z, Xiao C, Liu H, Liu Y, Wang L, Fan T, Zheng B, Tan F, Xue Q, Gao G, Li C, He J.
Zheng Y, et al. Among authors: liu y, liu h.
Front Cell Dev Biol. 2021 Mar 19;9:651406. doi: 10.3389/fcell.2021.651406. eCollection 2021.
Front Cell Dev Biol. 2021.
PMID: 33816503
Free PMC article.